Zoekresultaten - 7 results
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
(i.e., did not attend screening within 1 year of the initial invitation), 51% of whom stated difficulties in taking time off work. 64% of all respondents knew that HPV vaccination was available; only 34% ...
Early effects of human papillomavirus vaccination in Belgium.
Infections Papillomavirus Vaccines Poisson Distribution prevalence regression analysis Retrospective Studies Uterine Cervical Neoplasms Vaginal Smears Young adult Abstract: Human papillomavirus (HPV) ...
Are 20 human papillomavirus types causing cervical cancer?
vaccines, given their rarity in cervical cancers. Health Topics: Cancer Cancer Kanker Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: https://doi.org/10.1002/path.4424 ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Trottier, Helen Source: The Lancet Oncology, Volume 15, Issue 12 (2014) Keywords: HPV DNA meta-analyses neck cancer Abstract: BACKGROUND We aimed to provide updated information about the global estimates of ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
antibodies against the vaccine HPV types). We will assess clinical effectiveness by evaluating outcomes in all women, irrespective of the HPV DNA or serology status at enrolment. Evaluation by fine age and ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Adult Belgium Carcinoma, Squamous Cell Child Female Guideline Adherence HEALTH POLICY Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Insurance, Health, Reimbursement ...
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
regional programmes commenced in Portugal and Spain. Introduction of new methods of prevention, such as HPV screening and prophylactic HPV vaccination, can reduce the burden further, but this will require ...